Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Shares Acquired by Swiss National Bank

Swiss National Bank boosted its holdings in shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 3.1% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 224,000 shares of the biotechnology company’s stock after purchasing an additional 6,700 shares during […]

Related Keywords

Canada ,United States ,Switzerland ,Oregon ,Swiss ,Christopher Richard Anzalone ,Nasdaq ,Swiss National Bank ,Arrowhead Pharmaceuticals ,Arrowhead Pharmaceuticals Trading ,Royal Bank ,Citigroup ,Arrowhead Pharmaceuticals Company Profile ,Advisors Asset Management Inc ,Exchange Commission ,Quarter For Arrowhead Pharmaceuticals ,News Ratings For Arrowhead Pharmaceuticals Daily ,Oregon Public Employees Retirement Fund ,Arrowhead Pharmaceuticals Inc ,Cantor Fitzgerald ,Thrivent Financial For Lutherans ,Free Report ,National Bank ,Financial Advisors ,Asset Management ,Public Employees Retirement Fund ,Richard Anzalone ,Martin Javier San ,Arrowhead Pharmaceuticals Daily ,Nasdaq Arwr ,Arwr ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,